Abstract: Mixture of at least two esters selected from neopentylglycol dipelargonate, glycerol tripelargonate, pentaerythritol tetrapelargonate, and use thereof in cosmetic compositions for the care, the make-up, the protection from the sun and for the cleansing of the skin and skin appendages.
Abstract: The present invention relates to a solid makeup and/or care cosmetic composition in the form of a compact powder, comprising, in a physiologically acceptable medium, at least: a pulverulent phase, an emulsifying system, a hydrophilic gelling agent, an organic lake, and a hydrophilic active agent with hygroscopic properties, which is present in a content of between 1% and 40% by weight relative to the total weight of the composition, the said composition having a solids content of greater than or equal to 90%. The invention also relates to a process for manufacturing this cosmetic composition from an intermediate composition comprising an aqueous phase, and to a process for coating the skin with the said cosmetic composition.
Abstract: Disclosed is a novel antimicrobial means which is effective against various types of fungi including pathogenic true fungi and phytopathogenic filamentous fungi. An antimicrobial agent against fungi according to the present invention comprises, as an effective ingredient, cyanoacrylate polymer particles having an average particle diameter of less than 1000 nm, which particles contain at least one selected from the group consisting of amino acids, amino acid derivatives, oligomers and polymers thereof, saccharides and polysorbates, and contain no antimicrobial active ingredient effective against the fungi. The antimicrobial agent is particularly useful as a control agent against plant diseases caused by filamentous fungi.
Abstract: Methods of treating a condition resulting in nociceptive pain are provided. The method includes the step of administering to a mammal a therapeutically effective amount of a compound selected from the group consisting of diacetyl salicylic acid (DAS), aurin tricarboxylic acid (ATA), aurin quadracarboxylic acid (AQA), aurin hexacarboxylic acid (AHA), and/or a combination thereof.
Type:
Grant
Filed:
January 20, 2017
Date of Patent:
May 25, 2021
Assignee:
Aurin Biotech Inc.
Inventors:
Patrick L. McGeer, Moonhee Lee, Krista Kennedy, Edith G. McGeer, Douglas N. Bell
Abstract: The present invention provides formulations comprising polymers and therapeutics and methods for their manufacture. The present invention also provides medical devices coated with such formulations and methods for their manufacture. The drug-loaded polymer formulations, solutions, and films tailor the drug release characteristics for medical devices.
Type:
Grant
Filed:
June 7, 2018
Date of Patent:
May 25, 2021
Assignees:
South Dakota Board of Regents, Sanford Health
Inventors:
Gopinath Mani, Sujan Lamichhane, Jordan Anderson, Tyler Remund, Patrick W. Kelly
Abstract: The subject matter of the invention is an autopolymerisable two-component prosthetic base material and a method for its production comprising A) at least one liquid monomer component, and B) at least one powdered component, whereby the prosthetic material comprises in components (A) and/or (B) (i) at least one initiator or one initiator system for autopolymerisation, (ii) core-shell particles modified by an elastic phase, and (iii) at least one urethane (meth)acrylate.
Type:
Grant
Filed:
June 30, 2015
Date of Patent:
May 18, 2021
Assignee:
KULZER GMBH
Inventors:
Klaus Ruppert, Alfred Hohmann, Stephan Dekert
Abstract: Provided herein is a pharmaceutical composition for treating cancers. The pharmaceutical composition includes an oil-in-water (o/w) microemulsion, and an active pharmaceutical ingredient dissolved therein. The o/w microemulsion is comprised of an aqueous solution, an oil, and a surfactant, and is about 5-250 nm in diameter. Also provided herein are methods for treating cancers by use of the present pharmaceutical composition.
Abstract: The present invention provides a method of treating and preventing the common cold and associated secondary illnesses in a human subject, when the common cold is caused by viruses. The method comprises applying to the nasal passages of the human subject at ambient temperature, an effective amount of a pharmaceutical preparation comprising povidone-iodine (PVP-I) at a concentration of greater than 0.10% w/v and less than 2.5% in which at least 50% of the PVP-I is not associated with liposomes or other particulate carriers.
Abstract: An adjuvant composition includes a pH-sensitive carrier and a substance with stimulus to activate innate immune system. The adjuvant composition serves as a carrier which is highly safe and capable of efficient induction of CTL.
Abstract: The present disclosure provides a liquid eyeliner and a manufacturing method thereof. The liquid eyeliner includes following components by weight: acrylic acid octyl acrylamide copolymer or propylene ester octyl acrylamide copolymer ranging from 4-9%, propylene glycol provided ranging from 5-7%, ethylhexylglycerin ranging from 0.1-0.6%, butanediol ranging from 1.5-4%, sorbitan oleate ranging from 1-2%, emulsifier ranging from 1.4-2.2%, polydimethylsiloxane ranging from 6-9%, polyvinylpyrrolidone ranging from 3-4%, sorbitan sesquioleate ranging from 1.2-2%, butylated hydroxytoluene ranging from 0.1-0.2%, methylparaben ranging from 0.1-0.3%, propylparaben ranging from 0.05-0.15%, phenoxyethanol ranging from 0.6-1.2%, essence ranging from 0.1-0.3%, carbon black ranging from 1.5-2.8%, iron oxide black ranging from 30-45%, deionized water ranging from 22-30%, and plant extract ranging from 0.1-0.3%.
Type:
Grant
Filed:
August 9, 2019
Date of Patent:
May 4, 2021
Assignee:
HANGZHOU OCEAN PEARL INDUSTRIAL CO., LTD
Abstract: Systems and/or methods of treating and/or preventing nail disorders are disclosed herein. Also, disclosed herein are systems and/or methods of improving the appearance of a nail. A preferred embodiment of the present invention comprises a method of treating and/or preventing a nail disorder in a subject comprising topically applying a composition comprising a poly(urea-urethane)polymer and/or a poly(urea-urethane) pre-polymer to a nail of said subject, thereby treating and/or preventing said nail disorder.
Type:
Grant
Filed:
May 13, 2014
Date of Patent:
April 27, 2021
Assignee:
Chesson Laboratory Associates, Inc.
Inventors:
Lance L. Swick, Scott E. Neuville, Jerry S. Chesson
Abstract: Reduced-ethanol perfume compositions according to the invention comprise specific combinations of acrylates/VA copolymer and acrylates copolymer in an aqueous base or delivery vehicle. The perfume compositions according to the invention are easy to manufacture and provide an aqueous perfume composition that preserves aromatic integrity (intensity, duration and range), even in emulsion form. The most advantageous use of compositions of the invention are as parfums, eau de parfums, eau de toilettes, and colognes. However, the invention may also find use in many types of fragranced products, such as those used on the skin and hair of humans or animals, in cleaning products of all types, in air deodorizers, air fresheners, and more.
Abstract: The present disclosure relates to a hair care compositions comprising at least two or more polysaccharides, one or more monomeric polyols, and water. The compositions may also include polyglycerol esters of fatty acids. The hair care compositions are particularly useful in methods for imparting durable styling or shaping benefits and/or frizz control to hair.
Abstract: The present invention relates to an aqueous cosmetic composition based on a bicarbonate salt, said composition being stabilized by a pair of particular gelling agents, and also to the cosmetic use thereof as a deodorant. It also relates to a roll-on deodorant containing this composition.
Abstract: Disclosed is an efficacious, low-pH skin care composition that provides good sensory properties and has a low skin irritation potential. The low-pH composition includes an effective amount of a vitamin B3 compound and, optionally, one or more additional skin care actives to provide a skin health and/or appearance benefit. The low-pH composition also includes a pH buffer comprising lactic acid and sodium lactate, a polymer thickener comprising polyacrylate crosspolymer-6, and a silicone fluid having a kinematic viscosity of 100 cSt or less at 25° C. The pH of the low-pH composition can range from 2.0 to 5.0.
Type:
Grant
Filed:
June 3, 2020
Date of Patent:
March 30, 2021
Assignee:
The Procter & Gamble Company
Inventors:
Lu Zhang, Sudeep Chakravarty, Joseph Michael Zukowski
Abstract: Methods of synthesizing Bi2S3—CdS particles in the form of spheres as well as properties of these Bi2S3—CdS particles are described. Methods of photocatalytic degradation of organic pollutants employing these Bi2S3—CdS particles and methods of preventing or reducing microbial growth on a surface by applying these Bi2S3—CdS particles in the form of a solution or an antimicrobial product onto the surface are also specified.
Abstract: The present invention provides a sunscreen composition comprising two or more oil-soluble ultraviolet absorbers and composite silicone particles having an average particle diameter of 10 ?m or less.
Type:
Grant
Filed:
January 25, 2013
Date of Patent:
February 23, 2021
Assignee:
OTSUKA PHARMACEUTICAL CO., LTD.
Inventors:
Masahiko Tanaka, Miyoko Ogihara, Junko Kako
Abstract: A method of treating skin in need thereof is disclosed. The method can include topically applying to the skin a composition consisting of kakadu plum extract, glycerin, water, and optionally alcohol.
Type:
Grant
Filed:
October 25, 2018
Date of Patent:
February 16, 2021
Assignee:
Mary Kay Inc.
Inventors:
David Gan, Michelle Hines, Javier Aravena, Brian Jones
Abstract: A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also disclosed is a granulation process, especially a wet granulation process, for making the pharmaceutical composition.
Type:
Grant
Filed:
January 4, 2017
Date of Patent:
February 9, 2021
Assignee:
BIAL-Portela & C.A., S.A.
Inventors:
Teöfilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa